CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth. (Q64881042)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31178870%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

title

CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31178870%20AND%20SRC:MED&resulttype=core&format=json

triple-negative breast cancer

30 April 2020

main subject

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31178870%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

7

Pinku Mukherjee

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31178870%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Ru Zhou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31178870%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

author name string

Mahboubeh Yazdanifar

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31178870%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Lopamudra Das Roy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31178870%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Lynsey M Whilding

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31178870%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

Artemis Gavrill

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31178870%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

publication date

24 May 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31178870%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

published in

Frontiers in Immunology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31178870%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31178870%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

page(s)

1149

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31178870%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

30 April 2020

copyright license

start time

24 May 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

describes a project that uses

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC6543840/fullTextXML

inferred from PubMed Central ID database lookup

cites work

Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin

1 reference

12 December 2020

A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats

1 reference

12 December 2020

Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells.

1 reference

12 December 2020

The epithelial sialomucin, episialin, is sialylated during recycling

1 reference

12 December 2020

High density O-glycosylation on tandem repeat peptide from secretory MUC1 of T47D breast cancer cells

1 reference

12 December 2020

The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1.

1 reference

12 December 2020

Down-regulation of CXCR4 expression on human CD8+ T cells during peripheral differentiation.

1 reference

12 December 2020

Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer

1 reference

12 December 2020

The beta2 integrin CD11c distinguishes a subset of cytotoxic pulmonary T cells with potent antiviral effects in vitro and in vivo

1 reference

12 December 2020

Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells

1 reference

12 December 2020

Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients

1 reference

12 December 2020

Sustained antigen-specific antitumor recall response mediated by gene-modified CD4+ T helper-1 and CD8+ T cells.

1 reference

12 December 2020

Retargeting of human T cells to tumor-associated MUC1: the evolution of a chimeric antigen receptor

1 reference

12 December 2020

Triple-Negative Breast Cancer

1 reference

12 December 2020

The blockade of immune checkpoints in cancer immunotherapy

1 reference

12 December 2020

Dual targeting of ErbB2 and MUC1 in breast cancer using chimeric antigen receptors engineered to provide complementary signaling.

1 reference

12 December 2020

MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches

1 reference

12 December 2020

PD-1 and BTLA and CD8(+) T-cell "exhaustion" in cancer: "Exercising" an alternative viewpoint

1 reference

12 December 2020

The use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancer

1 reference

12 December 2020

The basic principles of chimeric antigen receptor design

1 reference

12 December 2020

Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor

1 reference

12 December 2020

Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity

1 reference

12 December 2020

The interplay of effector and regulatory T cells in cancer.

1 reference

12 December 2020

Wilms' tumor 1 (WT1) expression and prognosis in solid cancer patients: a systematic review and meta-analysis.

1 reference

12 December 2020

CD19 CAR Therapy for Acute Lymphoblastic Leukemia

1 reference

12 December 2020

Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia

1 reference

12 December 2020

A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis

1 reference

12 December 2020

Enhancing T cell therapy by overcoming the immunosuppressive tumor microenvironment

1 reference

12 December 2020

Driving CAR T-cells forward

1 reference

12 December 2020

Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma

1 reference

12 December 2020

Chimeric antigen receptors: driving immunology towards synthetic biology

1 reference

12 December 2020

Antibody-Guided In Vivo Imaging for Early Detection of Mammary Gland Tumors

1 reference

12 December 2020

Distinguishing Truncated and Normal MUC1 Glycoform Targeting from Tn-MUC1-Specific CAR T Cells: Specificity Is the Key to Safety.

1 reference

12 December 2020

Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells

1 reference

12 December 2020

CAR T-cell intrinsic PD-1 checkpoint blockade: A two-in-one approach for solid tumor immunotherapy.

1 reference

12 December 2020

Emerging immunotherapeutics in adenocarcinomas: A focus on CAR-T cells

1 reference

12 December 2020

A tumor specific antibody to aid breast cancer screening in women with dense breast tissue

1 reference

12 December 2020

Tumor Antigen Escape from CAR T-cell Therapy

1 reference

12 December 2020

Identifiers

DOI

10.3389/FIMMU.2019.01149

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31178870%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31178870%20AND%20SRC:MED&resulttype=core&format=json

30 April 2020

1 reference